AMBIT BIOSCIENCES CORP's ticker is AMBI and the CUSIP is 02318X100. A total of 23 filers reported holding AMBIT BIOSCIENCES CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $8,000 | -55.6% | 516 | -79.5% | 0.00% | -50.0% |
| Q2 2014 | $18,000 | +800.0% | 2,518 | +1024.1% | 0.00% | – |
| Q1 2014 | $2,000 | -86.7% | 224 | -86.0% | 0.00% | -100.0% |
| Q4 2013 | $15,000 | -21.1% | 1,600 | +31.3% | 0.00% | +50.0% |
| Q3 2013 | $19,000 | -34.5% | 1,219 | -70.6% | 0.00% | 0.0% |
| Q2 2013 | $29,000 | – | 4,144 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 2,079,569 | $18,966,000 | 13.32% |
| GREAT POINT PARTNERS LLC | 719,261 | $6,560,000 | 3.43% |
| Redmile Group, LLC | 367,602 | $3,353,000 | 0.40% |
| WEXFORD CAPITAL LP | 553,843 | $5,051,000 | 0.38% |
| SPHERA FUNDS MANAGEMENT LTD. | 148,468 | $1,354,000 | 0.31% |
| Eventide Asset Management | 131,100 | $1,196,000 | 0.19% |
| Orbimed Advisors | 1,490,769 | $13,596,000 | 0.17% |
| Baker Brothers Advisors | 747,954 | $6,821,000 | 0.09% |
| Artal Group S.A. | 250,000 | $2,280,000 | 0.08% |
| BAILARD, INC. | 35,000 | $319,000 | 0.05% |